Yu Shi

Atractylenolide-I Sensitizes Human Ovarian Cancer Cells to Paclitaxel by Blocking Activation of TLR4/MyD88-dependent Pathway

Jianming Huang, Guonan Zhang, Yu Shi et al. · Scientific Reports · 2014 · 79 citations · Full text

Life Sciences, Oncology, Pharmacology +12

Genetic variants of lncRNA HOTAIR and risk of epithelial ovarian cancer among Chinese women

Haijing Wu, Xiaofei Shang, Yu Shi et al. · Oncotarget · 2016 · 61 citations · Full text

Medicine, Genetics, Molecular Genetics +13

Efficacy and safety results from IMblaze370, a randomised Phase III study comparing atezolizumab+cobimetinib and atezolizumab monotherapy vs regorafenib in chemotherapy-refractory metastatic colorectal cancer

Johanna C. Bendell, Fortunato Ciardiello, Josep Tabernero et al. · Annals of Oncology · 2018 · 50 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways

Yuan Hu, Jiayu Jing, Yu Shi et al. · Translational Cancer Research · 2021 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17

Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study

Dengfeng Wang, Guonan Zhang, Chunrong Peng et al. · Journal of Ovarian Research · 2021 · 37 citations · Full text

Medicine, Oncology, Surgery +17